Natural killer T (NKT) cell ligand a-galactosylceramide inhibits tumor growth of murine renal cell carcinoma.

被引：0
|
作者：
Inoue, Takamitsu
Ohyama, Chikara
Hatakeyama, Shingo
Tsuchiya, Norihiko
Habuchi, Tomonori
机构：
来源：
JOURNAL OF UROLOGY | 2007年 / 177卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)30585-8
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：108 / 108
页数：1
相关论文
共 50 条
  • [21] Choline Deficiency Causes Colonic Type II Natural Killer T (NKT) Cell Loss and Alleviates Murine Colitis under Type I NKT Cell Deficiency
    Sagami, Shintaro
    Ueno, Yoshitaka
    Tanaka, Shinji
    Fujita, Akira
    Niitsu, Hiroaki
    Hayashi, Ryohei
    Hyogo, Hideyuki
    Hinoi, Takao
    Kitadai, Yasuhiko
    Chayama, Kazuaki
    PLOS ONE, 2017, 12 (01):
  • [22] Non clear cell renal cell carcinoma. 2008 update in renal tumor pathology
    Sibony, Mathilde
    Vieillefond, Annick
    ANNALES DE PATHOLOGIE, 2008, 28 (05) : 381 - 401
  • [23] The differential effect of stress on natural killer T (NKT) and NK cell function
    Oya, H
    Kawamura, T
    Shimizu, T
    Bannai, M
    Kawamura, H
    Minagawa, M
    Watanabe, H
    Hatakeyama, K
    Abo, T
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 121 (02): : 384 - 390
  • [24] Chitin stimulates adaptive T cell response to inhalant allergens through natural killer T (NKT) cell
    Lee, S. P.
    Choi, J. P.
    Lee, S. M.
    Kim, Y. M.
    Choi, S. J.
    Park, H. T.
    Cho, S. H.
    Kim, Y-K
    ALLERGY, 2014, 69 : 200 - 201
  • [25] β-galactosylceramide alters invariant natural killer T cell function and is effective treatment for lupus
    Morshed, Sufi R.
    Takahashi, Tsuyoshi
    Savage, Paul B.
    Kambham, Neeraja
    Strober, Samuel
    CLINICAL IMMUNOLOGY, 2009, 132 (03) : 321 - 333
  • [26] B7-1 ENHANCES NATURAL-KILLER CELL-MEDIATED CYTOTOXICITY AND INHIBITS TUMOR-GROWTH OF A POORLY IMMUNOGENIC MURINE CARCINOMA
    YEH, KY
    PULASKI, BA
    WOODS, ML
    MCADAM, AJ
    GASPARI, AA
    FRELINGER, JG
    LORD, EM
    CELLULAR IMMUNOLOGY, 1995, 165 (02) : 217 - 224
  • [27] A phase I study of the natural killer T-cell ligand α-Galactosylceramide (KRN7000) in patients with solid tumors
    Giaccone, G
    Punt, CJA
    Ando, Y
    Ruijter, R
    Nishi, N
    Peters, M
    von Blomberg, BME
    Scheper, RJ
    van der Vliet, HJJ
    van den Eertwegh, AJM
    Roelvink, M
    Beijnen, J
    Zwierzina, H
    Pinedo, HM
    CLINICAL CANCER RESEARCH, 2002, 8 (12) : 3702 - 3709
  • [28] Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand α-galactosylceramide
    Schmieg, J
    Yang, GL
    Franck, RW
    Tsuji, M
    JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (11): : 1631 - 1641
  • [29] Docosahexaenoic Acid Inhibits Cell Growth of Renal Cell Carcinoma
    Takayama, T.
    Zaima, N.
    Takaoka, N.
    Miyazaki, M.
    Tan, C.
    Sugiyama, T.
    Furuse, H.
    Mugiya, S.
    Setou, M.
    Ozono, S.
    UROLOGY, 2012, 80 (03) : S247 - S248
  • [30] Tumor-infiltrating lymphocyte diversity and clear cell renal cell carcinoma.
    Ferrall-Fairbanks, Meghan C.
    Chakiryan, Nicholas
    Chobrutskiy, Boris I.
    Kim, Youngchul
    Teer, Jamie K.
    Berglund, Anders
    Mule, James
    Fournier, Michelle
    Siegel, Erin M.
    Katende, Esther N.
    Blanck, George
    Manley, Brandon J.
    Altrock, Philipp M.
    CANCER RESEARCH, 2021, 81 (13)
12345